Spexis AG (STU:29Y) Momentum Rank : 2 (As of May. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Momentum Rank?

Spexis AG has the Momentum Rank of 2.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Spexis AG's Momentum Rank

For the Biotechnology subindustry, Spexis AG's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spexis AG's Momentum Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Spexis AG's Momentum Rank falls into.

Spexis AG Momentum Rank Related Terms

Thank you for viewing the detailed overview of Spexis AG's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (STU:29Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (STU:29Y) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

SPEXz:UK SPEX:Switzerland

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (STU:29Y) Headlines

No Headlines